Q2 FY2026 EarningsQ2 FY26 beat consensus across top and bottom lines: total revenue $71.7B vs. $70.2B expected, and adjusted EPS $7.78 vs. $7.60 mean consensus. Strong performance in Cigna Healthcare, with adjusted income up 17% YoY, offset a 27% decline in Pharmacy Benefit Services operating income due to contract renewals. Full-year FY26 adjusted EPS guidance was raised to at least $30.45, exceeding the trajectory implied by previous projections.
Financial report interval: 2026.03.30 - 2026.06.30
Overview: Cigna(CI) the Revenue is 71.67 B (+6.68%), Beat estimate;the EBIT is 2.676 B (+16.05%), Beat estimate;the EPS is 6.29 (+10.16%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
71.67B6.68%
70.18B4.47%
+1.48B2.21%
EBITExceed expectations
2.68B16.05%
2.57B11.60%
+0.10B4.45%
EPSMiss expectations
6.2910.16%
6.436712.73%
-0.14672.57%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf